Rubicon Research Ltd - 544578 - Filing Of Scheme Of Merger Of Kia Health Tech Private Limited (Wholly Owned Subsidiary) With Rubicon Research Limited - For Disclosure Purposes Only, In Terms Of The Exemption Under Paragraph 4 Of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 Dated June 20, 2023
Rubicon Research Ltd. board approved the scheme of amalgamation of its wholly-owned subsidiary, Kia Health Tech Private Limited, with the parent company. This merger aims to optimize resources, reduce compliance, and enhance operational efficiency.
Jul 22 2026 20:01:50
Rubicon Research Ltd - 544578 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Rubicon Research's wholly-owned subsidiary acquired its first US manufacturing facility in New Jersey for USD 2.9 million. This strategic move establishes a US manufacturing footprint, focusing on specialty and high-value products, with production expected to commence in 2027.
Jul 22 2026 15:30:37
Rubicon Research Ltd - 544578 - Record Date For Payment Of Final Dividend - Friday, August 7, 2026
Rubicon Research has set August 7, 2026, as the record date for its final dividend of ₹1.50 per equity share for FY26. This dividend is for fully paid-up equity shares and subject to shareholder approval.
Jul 20 2026 17:44:38
Rubicon Research Ltd - 544578 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - US FDA Inspection Of The Company'S Manufacturing Facility In Pithampur, Madhya Pradesh
Rubicon Research's Pithampur manufacturing facility underwent a US FDA inspection, resulting in 2 procedural observations. The company stated these observations do not relate to data integrity and is confident of timely resolution.
Jul 03 2026 17:34:51
Read More